Pfizer to Acquire Wyeth

The animal health businesses are the most likely parts of the merged Pfizer and Wyeth pharmaceutical businesses to concern the competition regulators, senior Pfizer executives have conceded. But, should assets have to be divested, it is unlikely to involve more than 10% of the combined veterinary business. Featured in this video are Jeffrey B Kindler, chief executive of Pfizer (left) and Bernard Poussot, chief executive of Wyeth.

Category:

Science & Technology

Tags:

• Jeffrey B Kindler
• Bernard Poussot

[Bergenbeacher]

@Sinekyre14

According to the most recent Secret Cabal Meeting of World-Running Jews, this is all according to plan. Didn't you attend? Oh wait, are you not... I'm sorry, forget what I said. Yeah, it's awful.

[Sinekyre14]

Both are jews, as well as the interviewer. Doesn't this bother anyone that the medical industry is dominated by jews who only hire other jews? Same as with the media and financial institutions in the US and internationally.